Boston Scientific wins expanded FDA nod for cryoablation system

Boston Scientific (NYSE:BSX) announced today that it received expanded FDA 510(k) clearance for its Visual Ice cryoablation system.

Related Keywords

Boston ,Massachusetts ,United States ,Peter Pattison ,Boston Scientific , ,Visual Ice ,Interventional Oncology ,